Blood Flow Restriction in MS Rehab: Efficacy and Safety

Blood flow restriction (BFR) training is emerging as a promising rehabilitation strategy for people with multiple sclerosis, according to recent clinical insights and systematic reviews published in 2024 and early 2025. This approach combines low-intensity exercise with partial occlusion of blood flow to working muscles, allowing patients to achieve strength and functional gains without exacerbating fatigue or triggering symptom flare-ups commonly associated with higher-intensity training.

Dr. Evan Cohen and Dr. Mark Mañago, clinicians specializing in neurologic rehabilitation, shared their perspectives on implementing BFR in MS rehabilitation during a Medscape feature published in April 2026. They emphasized that BFR enables individuals with MS to perform resistance exercises at intensities as low as 20–30% of their one-repetition maximum while still stimulating muscle hypertrophy and strength improvements comparable to traditional high-load training.

A systematic review published in Neurology International in November 2024 analyzed seven studies involving 71 participants with multiple sclerosis who underwent BFR training protocols. The review found that five of the studies combined BFR with strengthening exercises, while two incorporated it with aerobic exercise such as cycling or walking. In the strengthening-focused studies, participants typically performed exercises like leg presses, knee extensions, and heel raises under BFR conditions, with pressure applied via specialized cuffs to maintain arterial inflow while restricting venous return.

According to the review, BFRT in people with MS appears to be an effective, safe, and versatile strategy for rehabilitation aims. Researchers noted improvements in muscle strength, particularly in the lower extremities, alongside reductions in self-reported fatigue levels. These outcomes are clinically significant given that fatigue affects up to 80% of individuals with MS and often limits participation in physical activity and daily functioning.

A separate 12-week study published in early 2025 in the Archives of Physical Medicine and Rehabilitation evaluated the effects of low-load BFR training on middle-aged individuals with MS. Participants engaged in twice-weekly sessions involving resistance exercises at 20–30% load with BFR, compared to a control group performing similar exercises without restriction. The BFR group demonstrated significant gains in muscle strength, improved manual dexterity, and reduced fatigue scores, while maintaining stable neurological status throughout the intervention period.

Safety monitoring across the reviewed studies indicated no serious adverse events directly attributable to BFR when applied with appropriate screening and pressure protocols. Commonly used pressures ranged from 40–80% of limb occlusion pressure, adjusted individually based on limb circumference and systolic blood pressure. Transient sensations of discomfort or numbness were occasionally reported but resolved promptly upon cuff deflation, with no evidence of increased relapse rates or magnetic resonance imaging-detected lesion activity linked to the intervention.

Clinicians highlight that BFR’s ability to elicit meaningful physiological responses at low mechanical loads makes it particularly suitable for individuals with MS who experience weakness, spasticity, or balance impairments that limit tolerance to conventional exercise. By reducing joint stress while maintaining metabolic stress, BFR offers a way to counteract disuse atrophy and deconditioning without overexertion—a critical consideration in managing a condition where overexertion can temporarily worsen symptoms.

Despite encouraging results, experts caution that larger, longer-term randomized controlled trials are needed to establish optimal dosing parameters, long-term efficacy, and comparative effectiveness against other exercise modalities. Current evidence remains limited by small sample sizes and heterogeneity in protocols across studies. Nevertheless, the consistent signal of benefit across multiple pilot and feasibility studies supports further integration of BFR into multidisciplinary MS rehabilitation programs under professional supervision.

As of April 2026, BFR training is not yet a standard of care in MS management but is increasingly offered in specialized neurorehabilitation centers and outpatient clinics with expertise in neurologic physiotherapy. Patients interested in BFR should consult with a licensed physical therapist or neurologist to assess suitability, particularly considering factors such as cardiovascular history, clotting disorders, or severe hypertension, which may require modified approaches or contraindicate use.